What Researchers Did
Researchers conducted a review detailing the emergence, importance, manifestations, management, and treatment strategies for zygomycosis.
What They Found
They found a significant rise in zygomycosis incidence over the past decade, particularly in highly immunosuppressed patients due to increased cancer rates and medical treatments. High-risk groups include those with diabetes, malignancies, transplants, or iron overload, and treatment involves a three-part strategy with lipid formulations of amphotericin B as the antifungal agent of choice.
Canadian Relevance
This review does not have a direct Canadian connection as it is a general medical review without specific Canadian data or authors.
Study Limitations
As a review article, this study synthesizes existing literature and does not present new primary data, and its findings reflect the knowledge available up to 2006.